BLUE logo

Bluebird Bio (BLUE) Shareholders Equity

Annual Shareholders Equity

$194.54 M
+$60.20 M+44.82%

December 31, 2023


Summary


Performance

BLUE Shareholders Equity Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherBLUEbalance sheetmetrics:

Quarterly Shareholders Equity

-$5.79 M
-$58.77 M-110.92%

September 30, 2024


Summary


Performance

BLUE Quarterly Shareholders Equity Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherBLUEbalance sheetmetrics:

Shareholders Equity Formula

Shareholders Equity = Total Assets − Total Liabilities

BLUE Shareholders Equity Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year+44.8%-104.4%
3 y3 years-85.6%-104.3%
5 y5 years-89.7%-100.4%

BLUE Shareholders Equity Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-year-48.0%+44.8%-101.5%at low
5 y5-year-85.6%+44.8%-100.3%at low
alltimeall time-89.7%+449.0%-100.3%+89.6%

Bluebird Bio Shareholders Equity History

DateAnnualQuarterly
Sep 2024
-
-$5.79 M(-110.9%)
Jun 2024
-
$52.98 M(-59.6%)
Mar 2024
-
$131.05 M(-32.6%)
Dec 2023
$194.54 M(+44.8%)
$194.54 M(-12.6%)
Sep 2023
-
$222.54 M(-23.0%)
Jun 2023
-
$289.02 M(-18.5%)
Mar 2023
-
$354.74 M(+164.1%)
Dec 2022
$134.33 M(-64.1%)
$134.33 M(-15.4%)
Sep 2022
-
$158.86 M(-11.8%)
Jun 2022
-
$180.12 M(-31.6%)
Mar 2022
-
$263.26 M(-29.7%)
Dec 2021
$374.28 M(-72.4%)
$374.28 M(-57.0%)
Sep 2021
-
$870.53 M(-11.6%)
Jun 2021
-
$984.56 M(-18.0%)
Mar 2021
-
$1.20 B(-11.4%)
Dec 2020
$1.36 B(+5.5%)
$1.36 B(-11.0%)
Sep 2020
-
$1.52 B(-9.5%)
Jun 2020
-
$1.68 B(+50.1%)
Mar 2020
-
$1.12 B(-12.8%)
Dec 2019
$1.28 B(-31.8%)
$1.28 B(-12.7%)
Sep 2019
-
$1.47 B(-10.1%)
Jun 2019
-
$1.64 B(-7.7%)
Mar 2019
-
$1.77 B(-6.0%)
Dec 2018
$1.89 B
$1.89 B(-5.8%)
DateAnnualQuarterly
Sep 2018
-
$2.00 B(+37.3%)
Jun 2018
-
$1.46 B(-7.2%)
Mar 2018
-
$1.57 B(-3.3%)
Dec 2017
$1.62 B(+86.7%)
$1.62 B(+42.2%)
Sep 2017
-
$1.14 B(-4.9%)
Jun 2017
-
$1.20 B(+47.2%)
Mar 2017
-
$815.38 M(-6.2%)
Dec 2016
$869.44 M(+2.2%)
$869.44 M(+25.2%)
Sep 2016
-
$694.51 M(-8.5%)
Jun 2016
-
$759.29 M(-5.9%)
Mar 2016
-
$806.51 M(-5.2%)
Dec 2015
$850.50 M(+73.1%)
$850.50 M(-4.3%)
Sep 2015
-
$889.01 M(-3.3%)
Jun 2015
-
$918.97 M(+93.7%)
Mar 2015
-
$474.50 M(-3.4%)
Dec 2014
$491.26 M(+223.9%)
$491.26 M(+87.6%)
Sep 2014
-
$261.89 M(+58.0%)
Jun 2014
-
$165.76 M(+15.0%)
Mar 2014
-
$144.16 M(-4.9%)
Dec 2013
$151.67 M(-372.1%)
$151.67 M(-3.8%)
Sep 2013
-
$157.70 M(-2.2%)
Jun 2013
-
$161.27 M(+175.7%)
Mar 2013
-
$58.50 M(-204.9%)
Dec 2012
-$55.75 M(+0.1%)
-$55.75 M
Dec 2011
-$55.71 M
-

FAQ

  • What is bluebird bio annual stockholders equity?
  • What is the all time high annual shareholders equity for bluebird bio?
  • What is bluebird bio annual shareholders equity year-on-year change?
  • What is bluebird bio quarterly stockholders equity?
  • What is the all time high quarterly shareholders equity for bluebird bio?
  • What is bluebird bio quarterly shareholders equity year-on-year change?

What is bluebird bio annual stockholders equity?

The current annual shareholders equity of BLUE is $194.54 M

What is the all time high annual shareholders equity for bluebird bio?

bluebird bio all-time high annual stockholders equity is $1.89 B

What is bluebird bio annual shareholders equity year-on-year change?

Over the past year, BLUE annual stockholders equity has changed by +$60.20 M (+44.82%)

What is bluebird bio quarterly stockholders equity?

The current quarterly shareholders equity of BLUE is -$5.79 M

What is the all time high quarterly shareholders equity for bluebird bio?

bluebird bio all-time high quarterly stockholders equity is $2.00 B

What is bluebird bio quarterly shareholders equity year-on-year change?

Over the past year, BLUE quarterly stockholders equity has changed by -$136.83 M (-104.42%)